Insmed | Kundefordringer



Trade Debtors Endring Dato
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Cytokinetics USD 16.65M 16.41M 2024-12
DBV Technologies USD 20.1M 553K 2024-09
Dynavax Technologies USD 56.56M 9.65M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
Insmed USD 52.01M 9.7M 2024-12
Novartis USD 7.56B 594M 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Insmed Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.